Pharmaceutical brand naming is primarily driven by: trademark availability and regulatory approval.

In 2020, a global trademark filing in Class 5 occurred once every 53 seconds making trademark conflicts an important hurdle to overcome.

Even if a pharmaceutical company has successfully trademarked a brand name for its new product, a regulatory agency may reject a brand name because the risk of confusion with another name is too high.

We have the solutions for you to make sure you don’t experience issues in either space.

Maximize patient safety.
Bypass regulatory rejections.

Regulatory guidelines exist to define a consistent process and to ensure patient safety. We take the responsibility of balancing your commercial goals and regulatory acceptance very seriously, but when it comes to name development we take medication error prevention just as seriously.

Our creative teams work side-by-side with on-staff pharmacists. This means every name created at Addison Whitney not only adheres to the latest naming guidance of global regulatory agencies, but are evaluated in great detail to ensure patient safety due the minimization of medication errors due to name confusion.

Minimize legal risk.
Own your mark.

There is nothing more frustrating than falling in love with a name that you can’t own. Savvy commercial teams have become conditioned to accept processes which over-deliver an abundance of unusable names. We will never show you a name that has little to no chance of overcoming legal obstacles.

We want to level the playing field and reset industry expectations. As your trusted partner you can feel confident that we will get you to the finish line every time. We deliver more than just great names, but consistent value.

Industry veterans.
Assured success.

Unmatched expertise

Being a part of the Syneos Health Global Regulatory and Commercial Consulting Network allows our team to support any type of regulatory challenge.

Dedicated partnership beyond naming

Regulatory name submission strategy and documents · Name safety research / gap analysis · Canada name safety research and failure mode and effects analysis (FMEA) · Consults and rebuttals · USAN/INN/stem & class naming · Nonproprietary (USAN/INN) name evaluations research · Non-proprietary applications / submissions · Product labeling, packaging & trade dress research · Regulatory / safety review of container, carton, labels & packaging

Global experience

With locations across North America, Western Europe, Eastern Europe, Latin America and Asia Pacific, we have the ability to fully understand your challenges and the market in which your product will live post-approval.

Connected & influential

Our established relationships with active regulators across the globe allow us to stay ahead of changes or updates that may be published. Our team is at the forefront of revised guidance before it is even published.